Your session is about to expire
← Back to Search
Magnetogastrogram for Gastroparesis
N/A
Waitlist Available
Led By Leonard A Bradshaw, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children (ages 12-17) with functional dyspepsia
Total or partial gastrectomy patients
Must not have
Patients with a history of cardiac arrhythmias, taking anticoagulants, or greater than 80 years of age will be excluded
Normal participants with known intestinal complications
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is looking at a new way to assess bioelectrical activity in the gastrointestinal system in order to help characterize normal and pathologic physiology of the stomach.
Who is the study for?
This trial is for people aged 12-80 with conditions like gastroparesis, chronic nausea, or those who've had a gastrectomy. It includes diabetic patients and children with functional dyspepsia. Pregnant women, individuals over 80, those with claustrophobia, morbid obesity, cardiac arrhythmias or on anticoagulants cannot participate.
What is being tested?
The study tests a noninvasive technique called magnetogastrogram (MGG) to assess gastric electrical activity without radiation exposure. The goal is to distinguish normal from abnormal gastric activity which could improve treatment for stomach disorders.
What are the potential side effects?
Since MGG is noninvasive and doesn't involve drugs or radiation, significant side effects are not expected. However, the procedure requires lying still under equipment which might be uncomfortable for some participants.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a child aged 12-17 with stomach upset not caused by any known disease.
Select...
I have had all or part of my stomach removed.
Select...
I am between 12 and 80 years old.
Select...
I have been diagnosed with idiopathic gastroparesis.
Select...
I am a child aged 12-17 with ongoing nausea.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I do not have a history of heart rhythm problems, am not on blood thinners, and am under 80 years old.
Select...
I have known issues with my intestines but am otherwise healthy.
Select...
I am not pregnant or able to become pregnant.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Group I: GastroparesisExperimental Treatment1 Intervention
magnetogastrogram
Diabetes with and without gastroparesis ; Idiopathic gastroparesis
Group II: GastrectomyExperimental Treatment1 Intervention
magnetogastrogram
Total or partial gastrectomy group
Group III: Functional dyspepsiaExperimental Treatment1 Intervention
magnetogastrogram
Children with functional dyspepsia
Group IV: Control participantsExperimental Treatment1 Intervention
magnetogastrogram
Group without any gastrointestinal diseases.
Group V: Chronic nauseaExperimental Treatment1 Intervention
magnetogastrogram
Children with chronic nausea
Find a Location
Who is running the clinical trial?
Vanderbilt University Medical CenterLead Sponsor
902 Previous Clinical Trials
938,670 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,446 Previous Clinical Trials
4,331,682 Total Patients Enrolled
Leonard A Bradshaw, PhDPrincipal InvestigatorVanderbilt University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a child aged 12-17 with stomach upset not caused by any known disease.I have had all or part of my stomach removed.I am between 12 and 80 years old.I am a diabetic patient with or without gastroparesis, willing to undergo a gastric emptying test.I have been diagnosed with idiopathic gastroparesis.I do not have a history of heart rhythm problems, am not on blood thinners, and am under 80 years old.You are extremely overweight and may not be able to use the current SQUID devices.I am a child aged 12-17 with ongoing nausea.You are afraid of tight spaces and cannot stay still during the test.I have known issues with my intestines but am otherwise healthy.I am not pregnant or able to become pregnant.
Research Study Groups:
This trial has the following groups:- Group 1: Gastroparesis
- Group 2: Gastrectomy
- Group 3: Functional dyspepsia
- Group 4: Chronic nausea
- Group 5: Control participants
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger